Omada Health, Inc. (OMDA)

Market Cap	1.02B
Revenue (ttm)	283.30M +49.4%
Net Income	-6.30M
EPS	-0.13
Shares Out	59.45M
PE Ratio	n/a
Forward PE	47.75
Dividend	n/a
Ex-Dividend Date	n/a

Volume	983,170
Open	17.83
Previous Close	18.32
Day's Range	17.04 - 18.04
52-Week Range	10.28 - 26.92
Beta	n/a
Analysts	Buy
Price Target	22.92 (+33.1%)
Earnings Date	May 7, 2026

About OMDA

Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for emplo...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Jun 6, 2025
• Employees: 943
• Stock Exchange: NASDAQ
• Ticker Symbol: OMDA
• Website: https://www.omadahealth.com

Financial Performance

In 2025, Omada Health's revenue was $260.21 million, an increase of 53.24% compared to the previous year's $169.80 million. Losses were -$12.78 million, -72.89% less than in 2024.

Analyst Summary

According to 12 analysts, the average rating for OMDA stock is "Buy." The 12-month stock price target is $22.92, which is an increase of 33.10% from the latest price.

Price Target

$22.92

(33.10% upside)

Analyst Consensus: Buy